Shiri Nawrocki is a Dermatology physician. OpenAlex indexes 17 publications with 471 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
441 Stuart St Ste 404
Boston, MA 021165019
Telephone
857-317-2057Provider last certified this registry record 28 Feb 2024.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Incyte CorporationProgram year20255 payments
- Janssen Biotech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
30.1%Corticosteroid30.1%Hydrocortisone51%Clobetasol Propionate31%Betamethasone Dipropionate19%Part D<11 patientsAnti-infectives
27%Azole Antifungal18.4%Ketoconazole100%Part D≥13 patientsNitroimidazole Antimicrobial8.7%Metronidazole100%Part D<11 patientsDermatology
22.4%Corticosteroid16.3%Triamcinolone Acetonide100%Part D≥18 patientsalpha-Hydroxy Acid6.1%Ammonium Lactate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A case of dermatofibrosarcoma protuberans and reflectance confocal microscopy of a post‐surgical skin graft
Skin Research and Technology
2021 - A rare case of primary dermal clear cell sarcoma with focal epidermotropism: An entity difficult to distinguish from melanoma
Journal of Cutaneous Pathology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”